We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.


Download Mobile App

Eli Lilly and AbCellera Begin World's First Study of Potential COVID-19 Antibody Treatment in Humans

Eli Lilly and Company (Indianapolis, Ind, USA) has begun dosing patients in the world's first study of a potential antibody treatment designed to fight COVID-19.

Perry Health

Product Showcase


The StatStrip Xpress handheld POCT system brings lactate testing directly to the patient’s bedside. It provides a tur... Read more...